0000000000564253
AUTHOR
Hannah Muskett
showing 10 related works from this author
Additional file 5: Table S4. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in Unite…
2016
Final risk models at admission, 24Â h and end of calendar day 3. (DOC 44 kb)
Additional file 6: Figure S2. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in Unit…
2016
Area under the operating curve for clinical decision rules. (DOC 110 kb)
Additional file 5: Table S4. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in Unite…
2016
Final risk models at admission, 24Â h and end of calendar day 3. (DOC 44 kb)
Additional file 1: Table S1. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in Unite…
2016
Site of Candida invasive fungal disease (Nâ =â 359). (DOC 31 kb)
Additional file 3: Table S2. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in Unite…
2016
Therapies received, fungal colonisation, mortality and length of stay by invasive fungal disease subgroup. (DOC 61 kb)
Additional file 4: Table S3. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in Unite…
2016
Description of patients included at each time point in each of the development and validation samples. (DOC 37 kb)
Additional file 4: Table S3. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in Unite…
2016
Description of patients included at each time point in each of the development and validation samples. (DOC 37 kb)
Additional file 3: Table S2. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in Unite…
2016
Therapies received, fungal colonisation, mortality and length of stay by invasive fungal disease subgroup. (DOC 61 kb)
Additional file 2: Figure S1. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in Unit…
2016
Timing of Candida invasive fungal disease relative to critical care unit admission (Nâ =â 359). (DOC 27 kb)
Additional file 6: Figure S2. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in Unit…
2016
Area under the operating curve for clinical decision rules. (DOC 110 kb)